中华骨与关节外科杂志

参考文献

[1]Man GS,Mologhianu G.Osteoarthritis pathogenesis-a complex process that involves the entire joint.J Med Life,2014,7(1):37-41.

[2]Zhang LZ,Zheng HA,Jiang Y,et al.Mechanical and biologic link between cartilage and subchondral bone in osteoarthritis.Arthritis Care Res(Hoboken),2012,64(7):960-967.

[3]张立智,李双,吴文美,等.转化生长因子β信号与软骨的发生、发育和维持.中华骨与关节外科杂志,2018,11(7):556-560.

[4]赵晋,闫振宇,张立智.骨性关节炎软骨和软骨下骨之间信号通路.中华骨质疏松和骨矿盐疾病杂志,2016,9(2):193-198.

[5]Dickson MC,Martin JS,Cousins FM,et al.Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice.Development,1995,121(6):1845-1854.

[6]Albro MB,Nims RJ,Cigan AD,et al.Dynamic mechanical compression of devitalized articular cartilage does not activate latent TGF-beta.J Biomech,2013,46(8):1433-1439.

[7]Fava R,Olsen N,Keski-Oja J,et al.Active and latent forms of transforming growth factor beta activity in synovial effusions.J Exp Med,1989,169(1):291-296.

[8]He J,Cao W,Azeem I,et al.Transforming growth factor beta1 being considered a novel biomarker in knee osteoarthritis.Clin Chim Acta,2017,472:96-101.

[9]Blaney Davidson EN,van Caam AP,Vitters EL,et al.TGF-βis a potent inducer of Nerve Growth Factor in articular cartilage via the ALK5-Smad2/3 pathway.Potential role in OArelated pain?Osteoarthritis Cartilage,2015,23(3):478-486.

[10]Wang Q,Tan QY,Xu W,et al.Cartilage-specific deletion of Alk5 gene results in a progressive osteoarthritis-like phenotype in mice.Osteoarthritis Cartilage,2017,25(11):1868-1879.

[11]Zhen G,Cao X.Targeting TGFβsignaling in subchondral bone and articular cartilage homeostasis.Trends Pharmacol Sci,2014,35(5):227-236.

[12]Shen J,Li S,Chen D.TGF-βsignaling and the development of osteoarthritis.Bone Res,2014,2:14002.

[13]Shen J,Li J,Wang B,et al.Deletion of the transforming growth factorβreceptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice.Arthritis Rheum,2013,65(12):3107-3119.

[14]Little CB,Barai A,Burkhardt D,et al.Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.Arthritis Rheum,2009,60(12):3723-3733.

[15]Wang M,Sampson ER,Jin H,et al.MMP13 is a critical target gene during the progression of osteoarthritis.Arthritis Res Ther,2013,15(1):R5.

[16]de Kroon LMG,van den Akker GGH,Brachvogel B,et al.Identification of TGFβ-related genes regulated in murine osteoarthritis and chondrocyte hypertrophy by comparison of multiple microarray datasets.Bone,2018,116:67-77.

[17]Wu Q,Kim KO,Sampson ER,et al.Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.Arthritis Rheum,2008,58(10):3132-3144.

[18]Hopwood B,Tsykin A,Findlay DM,et al.Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling,WNT and transforming growth factor-beta/bone morphogenic protein signalling.Arthritis Res Ther,2007,9(5):R100.

[19]Guo SM,Wang JX,Li J,et al.Identification of gene expression profiles and key genes in subchondral bone of osteoarthritis using weighted gene coexpression network analysis.JCell Biochem,2018,119(9):7687-7695.

[20]Fang J,Xu L,Li Y,et al.Roles of TGF-beta 1 signaling in the development of osteoarthritis.Histol Histopathol,2016,31(11):1161-1167.

[21]Buckwalter JA,Brown TD.Joint injury,repair,and remodeling:roles in post-traumatic osteoarthritis.Clin Orthop Relat Res,2004,(423):7-16.

[22]Zhen G,Wen C,Jia X,et al.Inhibition of TGF-βsignaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis.Nat Med,2013,19(6):704-712.

[23]Suri S,Walsh DA.Osteochondral alterations in osteoarthritis.Bone,2012,51(2):204-211.

[24]Tang Y,Wu X,Lei W,et al.TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.Nat Med,2009,15(7):757-765.

[25]Kusumbe AP,Ramasamy SK,Adams RH.Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone.Nature,2014,507(7492):323-328.

[26]Wan M,Li C,Zhen G,et al.Injury-activated transforming growth factorβcontrols mobilization of mesenchymal stem cells for tissue remodeling.Stem Cells,2012,30(11):2498-2511.

[27]Ono N,Ono W,Mizoguchi T,et al.Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage.Dev Cell,2014,29(3):330-339.

[28]Xie L,Zeng X,Hu J,et al.Characterization of nestin,a selective marker for bone marrow derived mesenchymal stem cells.Stem Cells Int,2015,2015:762098.

[29]Xie L,Tintani F,Wang X,et al.Systemic neutralization of TGF-beta attenuates osteoarthritis.Ann N Y Acad Sci,2016,1376(1):53-64.

[30]Couchourel D,Aubry I,Delalandre A,et al.Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production.Arthritis Rheum,2009,60(5):1438-1450.

[31]Aaron RK,Racine J,Dyke JP.Contribution of circulatory disturbances in subchondral bone to the pathophysiology of osteoarthritis.Curr Rheumatol Rep,2017,19(8):49.

[32]Mu W,Xu B,Ma H,et al.Halofuginone attenuates osteoarthritis by rescuing bone remodeling in subchondral bone through oral gavage.Front Pharmacol,2018,9:269.

[33]赵晋,张立智,闫振宇.骨性关节炎中软骨和软骨下骨微结构病变的研究进展.中华实验外科杂志,2017,34:355-358.

[34]Blaney Davidson EN,Vitters EL,van Beuningen HM,et al.Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes:limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation.Arthritis Rheum,2007,56:4065-4073.

[35]Bakker AC,van de Loo FA,van Beuningen HM,et al.Overexpression of active TGF-beta-1 in the murine knee joint:evidence for synovial-layer-dependent chondro-osteophyte formation.Osteoarthritis Cartilage,2001,9(2):128-136.

[36]Ishihara K,Okazaki K,Akiyama T,et al.Characterisation of osteophytes as an autologous bone graft source:An experimental study in vivo and in vitro.Bone Joint Res,2017,6(2):73-81.

[37]Blaney Davidson EN,Vitters EL,Bennink MB,et al.Inducible chondrocyte-specific overexpression of BMP2 in young mice results in severe aggravation of osteophyte formation in experimental OA without altering cartilage damage.Ann Rheum Dis,2015,74(6):1257-1264.

[38]Hügle T,Geurts J.What drives osteoarthritis?-synovial versus subchondral bone pathology.Rheumatology(Oxford),2017,56(9):1461-1471.

[39]Hui AY,Mc Carty WJ,Masuda K,et al.A systems biology approach to synovial joint lubrication in health,injury,and disease.Wiley Interdiscip Rev Syst Biol Med,2012,4(1):15-37.

[40]Zielinski S,Bartels K,Cebulski K,et al.Evidence of proteolytic activation of transforming growth factor beta in synovial fluid.Adv Exp Med Biol,2000,477:477-481.

[41]Wang X,Dong C,Li N,et al.Modulation of TGF-βactivity by latent TGF-β-binding protein 1 in human osteoarthritis fibroblast-like synoviocytes.Mol Med Rep,2018,17(1):1893-1900.

[42]Blaney Davidson EN,Vitters EL,Mooren FM,et al.Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage.Arthritis Rheum,2006,54(5):1653-1661.

[43]van der Kraan PM.Differential role of transforming growth factor-beta in an osteoarthritic or a healthy joint.J Bone Metab,2018,25(2):65-72.

[44]Remst DF,Blom AB,Vitters EL,et al.Gene expression analysis of murine and human osteoarthritis synovium reveals elevation of transforming growth factorβ-responsive genes in osteoarthritis-related fibrosis.Arthritis Rheumatol,2014,66(3):647-656.

[45]Remst DF,Blaney Davidson EN,Vitters EL,et al.Osteoarthritis-related fibrosis is associated with both elevated pyridinoline cross-link formation and lysyl hydroxylase 2b expression.Osteoarthritis Cartilage,2013,21(1):157-164.

[46]Mathiessen A,Conaghan PG.Synovitis in osteoarthritis:current understanding with therapeutic implications.Arthritis Res Ther,2017,19(1):18.

[47]Wahl SM,Allen JB,Costa GL,et al.Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.J Exp Med,1993,177(1):225-230.

[48]Scanzello CR,Goldring SR.The role of synovitis in osteoarthritis pathogenesis.Bone,2012,51(2):249-257.

[49]Uchida K,Takano S,Matsumoto T,et al.Transforming growth factor activating kinase 1 regulates extracellular matrix degrading enzymes and pain-related molecule expression following tumor necrosis factor-αstimulation of synovial cells:an in vitro study.BMC Musculoskelet Disord,2017,18(1):283.

[50]Monteleone G,Mann J,Monteleone I,et al.A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappa B activation in gut inflammation.J BiolChem,2004,279(6):3925-3932.